SCHEMBL9669291

SCHEMBL9669291

O=c1cnc(-c2ccc3[nH]c(-c4cnccn4)cc3c2)c[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 6/20 0.41
CDK5R1 Q15078 6/20 0.41
PIM1 P11309 3/20 0.37
PIM2 Q9P1W9 3/20 0.37
PIM3 Q86V86 2/20 0.37
DYRK1A Q13627 2/20 0.36
GSK3B P49841 1/20 0.36
GCK P35557 1/20 0.36
NPY5R Q15761 1/20 0.36
MAPT P10636 1/20 0.36
CLK2 P49760 1/20 0.35
CLK3 P49761 1/20 0.35
CYP19A1 P11511 2/20 0.35
DHODH Q02127 1/20 0.34
METAP2 P50579 1/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CA P42336 1/20 0.34
PIK3CB P42338 1/20 0.34
PI4KA P42356 1/20 0.34
PIK3CG P48736 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9669299 0.85 CDC7 (0.40) CDK5CDK5R1PIM1PIM3DYRK1A
SCHEMBL9669332 0.82 CDK5 (0.41) CDK5CDK5R1PIM1PIM3DYRK1A
SCHEMBL9668089 0.80 CDK5 (0.38) CDK5CDK5R1METAP2
SCHEMBL9670176 0.79 PDGFRB (0.37) CDK5CDK5R1PIM1PIM3DYRK1A
SCHEMBL9667542 0.74 GPR119 (0.40) CDK5CDK5R1PIM1PIM2DYRK1A
SCHEMBL9668467 0.74 PDE3B (0.42) CDK5CDK5R1MAPT
SCHEMBL9670173 0.73 MAOB (0.40) CDK5CDK5R1
SCHEMBL9669416 0.72 MMP13 (0.39)
SCHEMBL31626826 0.71 CYP19A1 (0.59) CDK5CDK5R1PIM1GSK3BMAPT
SCHEMBL701368 0.71 CYP19A1 (0.59) CDK5CDK5R1PIM1GSK3BMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0223937-B1 INDOLES SUBSTITUTED WITH HETEROCYCLES, INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS Roche Diagnostics GmbH (DE) 1992-03-18 EP disclosed
US-4851406-A CARDIOVASCULAR DISORDERS, HYPOTENSIVE BOEHRINGER MANNHEIM GMBH (DE) 1989-07-25 US disclosed
EP-0223937-A1 Indoles substituted with heterocycles, intermediates, process for their preparation and medicaments Roche Diagnostics GmbH (DE) 1987-06-03 EP disclosed